-
Loading metrics
Open Access
Peer-reviewed
Research Article
Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
-
Sheriza N. Baksh ,
Contributed equally to this work with: Sheriza N. Baksh, G. Caleb Alexander, Stephan Ehrhardt
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: sbaksh4@jhu.edu
Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, United States of America
⨯ -
Jodi B. Segal ,
Roles Conceptualization, Data curation, Funding acquisition, Methodology, Resources, Software, Supervision, Writing – review & editing
¶‡ JBS, MMD and RRK also contributed equally to this work.
Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, United States of America, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America, Center for Health Services and Outcomes Research, Johns Hopkins University, Baltimore, MD, United States of America, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States of America
⨯ -
Mara McAdams-DeMarco ,
Roles Conceptualization, Formal analysis, Methodology, Supervision, Validation, Writing – review & editing
¶‡ JBS, MMD and RRK also contributed equally to this work.
Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, United States of America
⨯ -
Rita R. Kalyani ,
Roles Formal analysis, Methodology, Supervision, Validation, Writing – review & editing
¶‡ JBS, MMD and RRK also contributed equally to this work.
Affiliation Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America
⨯ -
G. Caleb Alexander ,
Contributed equally to this work with: Sheriza N. Baksh, G. Caleb Alexander, Stephan Ehrhardt
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing
Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, United States of America, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States of America
⨯ -
Stephan Ehrhardt
Contributed equally to this work with: Sheriza N. Baksh, G. Caleb Alexander, Stephan Ehrhardt
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – review & editing
Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America
⨯
Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
- Sheriza N. Baksh,
- Jodi B. Segal,
- Mara McAdams-DeMarco,
- Rita R. Kalyani,
- G. Caleb Alexander,
- Stephan Ehrhardt
- Published: October 15, 2020
- https://doi.org/10.1371/journal.pone.0240141